Evidence of meeting #44 for Status of Women in the 45th Parliament, 1st session. (The original version is on Parliament’s site, as are the minutes.) The winning word was symptoms.

A recording is available from Parliament.

On the agenda

Members speaking

Before the committee

Alon-Shenker  Associate Professor, Toronto Metropolitan University, As an Individual
Heale  Full Professor, Laurentian University, Centre for Research in Occupational Safety and Health
Flood  Executive Director, Women's Health Collective Canada
Norris  Cavarzan Chair in Women's Health Research, Edmonton Women's Health Research
Drapeau  Senior Vice President, Sales and Marketing, Purity Life Health Products LP, As an Individual
Debow  Founder, Menovate

The Vice-Chair Liberal Marilyn Gladu

I call this meeting to order.

Welcome to meeting number 44 of the House of Commons Standing Committee on the Status of Women.

Pursuant to Standing Order 108(2) and the motion adopted by the committee on Tuesday, January 27, the committee will begin its study of the labour force impacts of menopause and perimenopause.

Members are attending in person in the room and remotely using the Zoom application.

I'll make a few comments for the benefit of members and witnesses.

Please wait until I recognize you before speaking. For those participating on Zoom, click on the microphone icon to activate your mic, and please mute yourself when you're not speaking. You can choose French, English or floor for interpretation on the bottom. If you wish to speak, raise your hand, or use the “raise hand” function if you're on Zoom.

Committee members are going to ask questions in both official languages, so I'd like to recommend that the witnesses pick their interpretation now. Please address all comments through the chair.

Now we're going to welcome our witnesses.

We have Pnina Alon-Shenker, associate professor, Toronto Metropolitan University; Roberta Heale, full professor, Laurentian University; and Amy Flood, executive director, Women's Health Collective Canada.

We'll begin with opening statements.

Ms. Alon-Shenker, the floor is yours for five minutes.

Pnina Alon-Shenker Associate Professor, Toronto Metropolitan University, As an Individual

Thank you, Madam Chair, and thank you to the members of the committee for the opportunity to speak today.

My name is Pnina Alon-Shenker, and I'm an associate professor at Toronto Metropolitan University. I have studied age discrimination in the workplace for more than a decade. My most recent work, co-authored with Professor Asher Alkoby, addresses the gaps in legal protections for menopausal workers. This study was shared with the committee prior to this meeting.

Although available data suggest that menopause affects a large segment of Canadian workers, employment and labour laws remain largely silent on menopause. In the absence of explicit legal protections, employer-initiated menopause policies are rare, and menopausal workers encounter barriers to meaningful participation in the labour market. Indeed, women's labour force participation declines significantly as they age. This decline may be caused by a variety of factors, but there is some evidence to suggest that these include menopause-related challenges.

We found that there are very few litigated cases in Canada on menopause at work. The cases we discussed confirm previous findings that workers often lack the knowledge of what they experience and what they need, and when they do, the absence of inclusive workplace policies, together with persistent stigma, prevent them from seeking or receiving appropriate accommodation.

Menopause is often perceived as a personal problem rather than a human rights issue. Further, discrimination claims are reactive in nature, and they often mark a breakdown of the employment relationship in ways that are difficult to restore. Raising awareness through education of workers, employers, health professionals and adjudicators is critical not only for ensuring that such claims are brought forward and that they succeed, but also for preventing discriminatory practices in the first place.

The dearth of case law in this area is unsurprising. Menopause and its effects on women's health are still understudied. There is a substantial knowledge gap, lack of awareness and stigma surrounding menopause. Survey data show that unmanaged symptoms and the challenges experienced by menopausal workers contribute to reduced working hours, job loss and premature exit from the workplace. The impact on employers and the economy is also significant, including lost productivity and difficulty retaining top talent.

Other countries, such as the U.K. and Australia, have recognized the economic and social significance of these challenges and have conducted comprehensive parliamentary studies informed by extensive consultation with stakeholders. We are pleased to see that the Standing Committee on the Status of Women has now embarked upon a similar initiative. The U.K. and the Australian experiences make clear that there is no one solution that fits all workers and sectors, and that the way forward requires the introduction of integrated and coordinated measures to support menopausal workers.

Our study underscores the importance of exploring a multifaceted regulatory approach that would increase awareness, support employers' interest in retaining and attracting talent, effectively address stigma and silence and protect workers' choice and autonomy at work.

Indeed, Canada would benefit from a comprehensive national strategy that would promote the introduction of proactive regulatory measures and be accompanied by awareness-raising and education campaigns to break the silence surrounding menopause at work. Proactive regulatory measures that we recommend in particular include the introduction of workplace policies, menopause training, paid leave of absence and a stronger right to request flexible work arrangements.

Further, we argue that there is an important expressive value in explicitly recognizing menopause under human rights legislation at the intersection of age, sex and disability. This could help raise awareness, facilitate the development of menopause-related workplace policies, promote proactive duty to remove barriers, and create a clearer pathway to accommodation requests and more inclusive workplaces.

Finally, our review of other jurisdictions observed a normative shift towards a universal right to workplace accommodation. Focusing on the actual need for accommodation regardless of the individual's physical or mental condition would ensure the effective removal of social and environmental barriers that restrict meaningful participation in society of all Canadians.

Indeed, research shows that women wish to remain active in the labour market and are often able to do so with simple and inexpensive support and adjustments.

This approach would also help address concern—

The Vice-Chair Liberal Marilyn Gladu

Could you wrap up your comments? Thank you.

3:50 p.m.

Associate Professor, Toronto Metropolitan University, As an Individual

Pnina Alon-Shenker

Can I finish the last sentence?

The Vice-Chair Liberal Marilyn Gladu

Yes.

3:50 p.m.

Associate Professor, Toronto Metropolitan University, As an Individual

Pnina Alon-Shenker

This approach would also help address the concern that designing menopause-specific measures may inadvertently reinforce stigma and prejudice.

Thank you so much for your consideration of these matters.

The Vice-Chair Liberal Marilyn Gladu

Thank you so much. I'm sorry, but we are very tight for time with these votes today.

Ms. Heale, the floor is yours for five minutes.

Roberta Heale Full Professor, Laurentian University, Centre for Research in Occupational Safety and Health

Thank you very much for inviting me here today.

I have been a nurse practitioner for close to 27 years, and I'm a full professor at Laurentian University. I continue to practise as a nurse practitioner, and I opened the Virtual Menopause Clinic four years ago.

I've learned that women in mid-life undergo profound physiological changes that result in a whole host of symptoms. Every woman is different, and the symptoms they experience and the severity of them can vary considerably, but perimenopause and menopause symptoms impact all areas of a woman's life—most definitely, work.

Many of my patients have told me the impacts of these symptoms. Comments like, “If you hadn't treated me, I would have had to quit work,” prompted me to develop a pan-Canadian survey to gather data about this experience. The survey is still live, but the preliminary findings are concerning: 47% of the survey participants reported that they've missed work because of symptoms; 45% have reduced work hours; 43% have taken sick time or vacation time to manage their menopause symptoms; and 31% are considering leaving their work.

Overall, the findings are not surprising. Menopause symptoms significantly impact work. In addition, most workplaces lack policy, awareness or accommodations. The findings mimic what we know. Up to 10% of women leave the workforce because of menopause symptoms. These are their peak earning years, so it's going to have an impact on them financially for the rest of their lives. The cost to women is enormous.

The cost to organizations and employers is huge, with an estimated $237 million annually lost to menopause care and symptoms, and an estimated cost to organizations of up to $50,000 to replace senior employees.

We can't talk about menopause at work without talking about the barriers to receiving care in menopause. The lack of accessibility to knowledgeable menopause care providers is very common. Accessibility to affordable treatment is a barrier, and more and more women are turning to private pay. Hopefully, when all provinces have direct remuneration for NPs, this will solve part of the problem. If a woman doesn't have drug benefits or coverage for things like counselling, they have to pay out of pocket, and that menopause treatment is prohibitive. It's very expensive.

There are other related issues. The ongoing black box warnings on vaginal estrogen products have been removed by the FDA in the U.S. but remain in Canada. This contributes to the confusion and the tsunami of information and misinformation that women experience about menopause care, as well as the hesitancy of some providers to provide them with actual care.

There are many strategies that could be considered at the federal level. First, continue to prioritize menopause hormone therapy in the national pharmacare plan and trigger reviews of products so that the approvals are aligned with evidence. Next, continue to ensure that all jurisdictions develop direct remuneration for NPs to help reduce costs for women. Also, consider the establishment of regional centres of excellence—I know there are a few across the country right now—to train health care providers and create public education programs, with the goal being to move menopause care back into primary health care.

Another is to consider menopause as an issue of equity. Again, the U.K. has legislation to eliminate discrimination against women when, related to their symptoms, they need to adjust their work. Advocate for workplace environment standards, such as policy frameworks that emphasize things like physical workspace adjustments, ventilation or even just access to appropriate washroom facilities. Review national health workplace strategies, such as in England and Scotland, which support menopausal transition in the workplace—strategies such as employers signing pledges to implement formal menopause policies. Finally, consider funding and developing a national clinical guideline, which truly reflects current evidence and practice, for the management of women during the menopause transition.

Menopause at work impacts millions of women. Providing care to women during the menopause transition has shown me how much needs to be done to ensure optimal workplace environments during this critical stage.

I look forward to the report from this committee.

Thank you.

The Vice-Chair Liberal Marilyn Gladu

Thank you so much.

Ms. Flood, you have the floor for five minutes.

Amy Flood Executive Director, Women's Health Collective Canada

Thank you very much. Good afternoon, everyone.

My name is Amy Flood. I'm the executive director of the Women's Health Collective Canada.

Women's Health Collective Canada is a national alliance of five of the leading women's health and research institutes, which are working together to advance women's health through research, advocacy, education and coordination of national action.

Thank you for the opportunity to represent women's health research, the topic of menopause and its importance to the workplace and productivity. Bringing people together across health, research, innovation and policy is exactly how progress happens in women's health. That's why conversations like this matter.

Women's health remains underfunded, under-researched and, too often, misunderstood. In Canada, we are 51% of the population, 47% of the workforce and are forecasted to own nearly 50% of our country's wealth by 2030, yet only 7% of health research funding is dedicated specifically to women's health.

For decades, clinical trials and research were largely designed around male bodies with male norms. While policies have evolved to require the inclusion of women, gaps in evidence and care persist today. This results in a system that has never been fully designed for women and we see the consequences. Women are waiting years for diagnoses. They are misdiagnosed or they are living with untreated conditions that affect not only their health, but their ability to fully participate in the workforce and in life in general.

These are not isolated issues. They are systemic outcomes of decades of underinvestment. They show up every day. Women account for most adverse drug reactions, and this is linked to how medications have historically not been tested on women. Nearly half of adolescent girls are missing school or activities due to menstrual health challenges, and 40% of mothers are considering leaving the workforce during the postpartum period.

At the same time, women are living longer than men, but spending 24% of that time in poor health. The majority of that 24% of time in poor health is during the critical working years.

Hormones and the hormonal transition through perimenopause and menopause are one of the largest drivers of the women's health equity gap in Canada. Approximately 10 million women in Canada are over the age of 40, encompassing those in perimenopause, menopause and post-menopause. Perimenopause symptoms are showing up earlier in women today. Health care providers report seeing women in their late thirties and forties experiencing perimenopausal symptoms such as irregular periods, hot flashes, brain fog and mood swings.

An estimated one in 10 women steps away from the workforce due to unmanaged menopause symptoms. Forty per cent of women in their sixties still experience menopause symptoms. It is estimated that menopause symptoms cost the Canadian economy approximately $3.5 billion annually. Employers incur around $237 million each year due to lost productivity. Women face $3.3 billion in lost income stemming from reduced work hours, decreased pay or exiting the workforce entirely. Menopause-related symptoms lead to approximately 540,000 lost work days per year in Canada. Of working women, 32% reported that their menopause symptoms negatively affected their job performance. Factors contributing to these trends were increased stress levels, environmental toxins, endocrine disruptors, diet and lifestyle changes, hormone treatments, etc.

Menopause research in Canada is critically needed. Governments need strong data to create health campaigns and funding programs for menopause care. Canada is behind countries like the U.K., which is making menopause a public health priority. We lack Canadian-specific data. We lack knowledge in health care. There's limited research on the long-term effects of menopause hormone therapy and treatments. There is a lack of mental health and menopause support in the workforce. We lack knowledge in the workplace and the economy.

A 2024 report by the Women's Health Research Institute found that a third of women's work performance was affected by their symptoms, yet their workplaces lacked the policies to support them.

We're asking that employers consider these top six things to help women through their menopause transition.

Normalize the workplace conversation. Create a culture where menopause can be discussed openly and without stigma. Education awareness helps employees feel supported and reduces the barriers to seeking help.

Train managers. Equip your leaders with the knowledge and confidence to understand menopause symptoms. Have supportive conversations and provide appropriate accommodations when needed.

Offer flexibility. Flexible work arrangements, including hybrid work-adjusted schedules and flexibility for medical appointments, can help manage symptoms while remaining productive and engaged.

Enhance benefits and support.

4 p.m.

Liberal

The Vice-Chair Liberal Marilyn Gladu

Could you wrap up your comments? Thank you.

4 p.m.

Executive Director, Women's Health Collective Canada

Amy Flood

The cost of support is far less significant than the cost of short-term and long-term disability.

Support research and evidence-based menopause solutions.

4 p.m.

Liberal

The Vice-Chair Liberal Marilyn Gladu

Thank you very much. I'm sorry about that. We're pinched for time.

We're going to start our first round of questions with Madam Vien.

You have six minutes.

4 p.m.

Conservative

Dominique Vien Conservative Bellechasse—Les Etchemins—Lévis, QC

Thank you very much, Madam Chair.

I'm so happy that these three women are here with us today. I was one of those who advocated for this cause, but I didn't have to do it for long, because my colleagues around the table understood. Many of us are in perimenopause or menopause. We've experienced certain problems and felt various symptoms.

When I started asking questions myself, I realized that few people around me, even those in the medical community, were able to answer them. I've also seen many people experiencing anxiety because of what they were going through. Why is that? It's because they didn't talk about it. It's true, we don't talk about it. However, the more we keep silent on this, the more women will remain on the sidelines and go through this all alone. The workplace won't change.

My first questions will be for Ms. Alon-Shenker.

If I understand correctly, you're interested in the workplace. We naturally think of brain fog, for example, which means that women can no longer be as quick as they used to be in terms of performance or memory. They struggle to find the right words, they feel guilty, they don't talk about it much and they try to hide it. They may be afraid of losing their job or missing out on a promotion. All three of you said that there was a lack of information and research on this.

Let's start with the immediate environment. How can we change the workplace to ensure that managers and colleagues are informed so that women feel much better received and have an easier time of it? We mustn't forget the union either.

4:05 p.m.

Associate Professor, Toronto Metropolitan University, As an Individual

Pnina Alon-Shenker

Absolutely. Thank you so much for the question. I think it's really important.

I and others have experienced that. I'm thinking about the people who are not lucky enough to have flexibility in their workplace, whereas professionals and office workers have much more flexibility. There are people who need to be physically available at a certain time, in a certain workplace. Without that.... Only adjustments in the workplace can help.

The problem starts earlier, as Madam Chair identified. The knowledge gap—the idea that some workers are not even aware that what they're experiencing is menopause.... There are some symptoms that are not much connected to one another, and you don't know how to put your finger on it, whether it is menopause. Once you realize it is menopause, is it a personal problem that affects your performance at work, or is it a human rights issue that deserves the attention of unions and employers, in the sense of requesting accommodation? There's no discussion around that because it's taboo and there's a lot of embarrassment and reluctance to share information with the human resources office or employers in a lot of workplaces—

Dominique Vien Conservative Bellechasse—Les Etchemins—Lévis, QC

I'm sorry to interrupt you, Ms. Alon-Shenker, but where or with whom should we start?

Do we need legislation or regulations?

Should the minister responsible for labour issues be involved? I myself held that portfolio at the provincial level, but I was perhaps less aware of this issue at the time, since I wasn't in the same situation.

Where should we start?

4:05 p.m.

Associate Professor, Toronto Metropolitan University, As an Individual

Pnina Alon-Shenker

From the review we have done, in the study, there is nothing in the legislation that directly, explicitly mentions menopause. You can make some connections within the existing protections, but there is nothing.... Yes, I'm in favour of legislation.

First and foremost, there has to be more research on the impacts of menopause on women in the workplace. Then there has to be a campaign to increase awareness among the general public, inform health care professionals and help women understand what they're experiencing. There has to be more awareness in the workplace. For example, in the U.K., the recommendation of a parliamentary committee was to appoint a menopause ambassador. The U.K. government adopted that recommendation and appointed a menopause employment champion who works with stakeholders and recommends best practices and policies.

I would even go further and mandate a menopause policy in the workplace, because when it comes through voluntary compliance.... We don't say, “compliance”. In other areas, we have had bad experiences with respect to trusting what employers can do.

4:05 p.m.

Conservative

Dominique Vien Conservative Bellechasse—Les Etchemins—Lévis, QC

Thank you very much, Ms. Alon-Shenker. I don't have a lot of time. That's the frustrating part of committee work.

Ms. Flood, you mentioned hormones and hormone therapy. Ms. Heale, you also mentioned them. In Quebec, we often hear about bioidentical hormones. A very interesting documentary called Loto-Méno has really raised women's awareness of the symptoms. Some women even watched the documentary with their husbands or partners.

In Quebec, hormone therapy is free for women. What's the current situation in Canada regarding free access to hormone therapy?

The question is for all three witnesses.

The Vice-Chair Liberal Marilyn Gladu

Unfortunately, that's the end of the six minutes, but I would invite all of the witnesses, if they have comments to respond here, to please send them to the clerk. The committee would be very happy to get them.

Now we'll go to Ms. Nathan for six minutes.

Juanita Nathan Liberal Pickering—Brooklin, ON

Thank you, Madam Chair. Through you, my first question is for Professor Alon-Shenker.

Professor, when I introduced this study, one of the things I heard repeatedly from women and advocates on this matter was that they often did not know whether they had any right to ask for support at work.

From the perspectives of human rights and labour law, do you believe that Canada's existing legal framework adequately protects workers experiencing menopause and perimenopause? Are women falling through gaps in our current accommodation system? I know that women normally quietly reduce their hours or just stop working altogether. They'll make up excuses so as not to go to work.

I want to ask you for your perspective on that.

4:10 p.m.

Associate Professor, Toronto Metropolitan University, As an Individual

Pnina Alon-Shenker

I think our existing laws inadequately protect women and do not encourage them to come forward with their requests.

We have human rights legislation, and it does address prohibited grounds that could be relevant to menopause, including disability, age and sex, but our system is very reactive, in the sense that only once a person has been adversely affected by discrimination they may file a complaint. The system is very individualized, so we are relying, in terms of enforcement, on an individual victim filing a complaint and arguing their case.

When there are no policies in the workplace that address the issue of menopause—a process of requesting accommodation—women lack the knowledge, are reluctant and even, as surveys suggest, hide their symptoms. Hiding symptoms could be very dangerous in terms of health and safety and can, as you mentioned, lead to a premature exit from the workplace.

Certainly, I don't think we're doing enough. I think it's important to establish a pathway—explicit rules, explicit processes—similar to what we have in federal legislation with regard to requests for flexible work arrangements. There's a process, you know it exists and you know you can request. There's a process for the employer to either accept or reject the request, with reasons.

Yes, there can be policies with regard to adjustments and support for menopause symptoms.

Juanita Nathan Liberal Pickering—Brooklin, ON

Thank you for that response.

You're saying that it's more so the policies and we have to explicitly recognize them. It's less about legislation and more about implementation of awareness among employers.

4:10 p.m.

Associate Professor, Toronto Metropolitan University, As an Individual

Pnina Alon-Shenker

I think it's about legislation, and legislation can work in various ways.

First, legislation can mandate a policy in the workplace. In the U.K., for example, they mandate an action plan. Just as with equity legislation, you need an action plan. Show us how you implement and promote a menopause-inclusive environment. How do you review your current policies, amend them and remove barriers? This could be done through legislation because you mandate those action plans or provide some model policies that workplaces need to follow.

Another way to legislate is to explicitly recognize menopause as a prohibited ground. Pregnancy is recognized explicitly under sex. Menopause or other reproductive health conditions are not, so it's not clear. Is it under age? Is it a disability? Some symptoms may qualify as a disability.

In the case law, we moved from the medical model of disability to the social model of disability, which doesn't look at the medical condition of the person but looks at the barriers in the workplace. Menopause works in that way. Even if menopause is not considered a disability because it's a normal, common life stage that every middle-aged woman will go through, society or workplaces still perceive that as an impairment, to some extent. There's some stigma around that. There's prejudice. When they don't provide adequate supports and adjustments, these women are adversely affected.

Legislation has a huge role here, absolutely.

Juanita Nathan Liberal Pickering—Brooklin, ON

Thank you so much for that.

I'll move on to Ms. Heale.

I want to talk about how well the health care professionals are educated on this. In school, when they go through their medical training, how much time is spent on explaining this to them? As we know, most physicians are male doctors. I just want to know, from your experience, how this is treated.

The Vice-Chair Liberal Marilyn Gladu

I'm very sorry, but you're at the end of your six minutes.

I invite you, Ms. Heale, to respond to the clerk in writing.

Ms. Larouche, you have the floor for six minutes.